CT
RPRX icon

Clearstead Trust’s Royalty Pharma RPRX Stock Holding History

Clearstead Trust’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.4K Hold
132
– – ﹤0.01% 693
2026
Q1 		$6.33K Hold
132
– – ﹤0.01% 701
2025
Q4 		$5.1K Sell
132
-58
-31% -$2.21K ﹤0.01% 756
2025
Q3 		$6.7K Buy
190
+58
+44% +$2.1K ﹤0.01% 690
2025
Q2 		$4.76K Buy
132
+33
+33% +$1.09K ﹤0.01% 765
2025
Q1 		$3.08K Buy
+99
New +$3.14K ﹤0.01% 705

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clearstead Trust's RPRX Position: Q2 2026 in Review

Clearstead Trust held its Royalty Pharma (RPRX) position steady in Q2 2026 at 132 shares worth $7.4K. The position accounts for ﹤0.01% of the portfolio, ranked #693.

Clearstead Trust first reported a position in RPRX in Q1 2025 and has held it in 6 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Clearstead Trust held 132 shares of Royalty Pharma worth $7.4K as of Q2 2026.
  • Clearstead Trust left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #693 holding.
  • Clearstead Trust first reported a position in Royalty Pharma in Q1 2025 and has held it in 6 quarters since.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.